We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+22.59%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$204B
AUM Growth
+$33.9B
Cap. Flow
+$1.02B
Cap. Flow %
0.5%
Top 10 Hldgs %
17%
Holding
3,435
New
201
Increased
1,862
Reduced
1,124
Closed
116

Sector Composition

Rank Sector Weight
1 Technology 19.78%
2 Healthcare 12.43%
3 Financials 11.93%
4 Consumer Discretionary 9.96%
5 Industrials 8.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PVBC
3201
DELISTED
Provident Bancorp
PVBC
$154K ﹤0.01%
19,487
LNAI
3202
Lunai Bioworks
LNAI
$8.89M
$154K ﹤0.01%
456
FLNA
3203
Filana Therapeutics
FLNA
$48.3M
$154K ﹤0.01%
+49,937
New +$226K
MRKR icon
3204
Marker Therapeutics
MRKR
$18.8M
$153K ﹤0.01%
7,371
+912
+14% +$19.9K
SD icon
3205
SandRidge Energy
SD
$514M
$152K ﹤0.01%
117,781
-65,555
-36% -$98.4K
TELA icon
3206
TELA Bio
TELA
$32.9M
$152K ﹤0.01%
+11,686
New +$153K
NEXT icon
3207
NextDecade
NEXT
$1.78B
$151K ﹤0.01%
69,678
+20,752
+42% +$38K
CSBR icon
3208
Champions Oncology
CSBR
$74.6M
$149K ﹤0.01%
+15,491
New +$132K
GSG icon
3209
iShares S&P GSCI Commodity-Indexed Trust
GSG
$998M
$148K ﹤0.01%
14,310
-8,498
-37% -$80.9K
BLPH
3210
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$146K ﹤0.01%
+11,586
New +$162K
LMST
3211
DELISTED
Limestone Bancorp, Inc. Common Stock
LMST
$144K ﹤0.01%
+10,875
New +$132K
ACOR
3212
DELISTED
Acorda Therapeutics
ACOR
$142K ﹤0.01%
1,602
-982
-38% -$104K
PTRS
3213
DELISTED
Partners Bancorp Common Stock
PTRS
$141K ﹤0.01%
+21,396
New +$149K
HPR
3214
DELISTED
HighPoint Resources Corporation
HPR
$141K ﹤0.01%
9,493
-4,741
-33% -$68.8K
SCPH
3215
DELISTED
scPharmaceuticals
SCPH
$140K ﹤0.01%
+18,959
New +$167K
VERO
3216
DELISTED
Venus Concept
VERO
$139K ﹤0.01%
+240
New +$153K
TRAK icon
3217
ReposiTrak
TRAK
$154M
$137K ﹤0.01%
+32,293
New +$156K
ACET icon
3218
Adicet Bio
ACET
$85.3M
$136K ﹤0.01%
561
-216
-28% -$42.4K
SB icon
3219
Safe Bulkers
SB
$796M
$135K ﹤0.01%
110,082
SNFCA icon
3220
Security National Financial
SNFCA
$244M
$135K ﹤0.01%
+27,423
New +$119K
GRTX
3221
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$135K ﹤0.01%
+18,833
New +$200K
NMRD
3222
DELISTED
Nemaura Medical, Inc. Common Stock
NMRD
$134K ﹤0.01%
+14,458
New +$103K
SOLY
3223
DELISTED
Soliton, Inc.
SOLY
$132K ﹤0.01%
16,918
+5,821
+52% +$57.3K
KNTK icon
3224
Kinetik
KNTK
$3.72B
$131K ﹤0.01%
20,560
-10,926
-35% -$74.6K
UBP
3225
DELISTED
Urstadt Biddle Properties Inc.
UBP
$131K ﹤0.01%
+12,938
New +$140K

Similar funds

Charles Schwab's Q2 2020 Portfolio in Review

As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

  • Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
  • Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
  • Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
  • Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
  • Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
  • Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
  • Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.

Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.